Catalyst Wire Dossier Catalyst Wire Dossier

Belviq

lorcaserin · Eisai Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Belviq, covering 2013-08-20 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Lorcaserin in Obesity: Identification of CNS Targets Using FMRI [Phase 4]

See pricing